EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors

Dan Dou iD, Jayne Aiken iD, Erika L F Holzbaur iD

Journal of Cell Biology · 2024

DOI: 10.1083/jcb.202307092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cell Biology, 2024. Verfasst von Dan Dou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Parkinson Disease, Synaptic Vesicles, rab3A GTP-Binding Protein. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIGMS NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gain-of-function mutations in the LRRK2 gene cause Parkinson’s disease (PD), characterized by debilitating motor and non-motor symptoms. Increased phosphorylation of a subset of RAB GTPases by LRRK2 is implicated in PD pathogenesis. We find that increased phosphorylation of RAB3A, a cardinal synaptic vesicle precursor (SVP) protein, disrupts anterograde axonal transport of SVPs in iPSC-derived human neurons (iNeurons) expressing hyperactive LRRK2-p.R1441H. Knockout of the opposing protein phosphatase 1H (PPM1H) in iNeurons phenocopies this effect. In these models, the compartmental distribution of synaptic proteins is altered; synaptophysin and synaptobrevin-2 become sequestered in the neuronal soma with decreased delivery to presynaptic sites along the axon. We find that RAB3A phosphorylation disrupts binding to the motor adaptor MADD, potentially preventing the formation of the RAB3A–MADD-KIF1A/1Bβ complex driving anterograde SVP transport. RAB3A hyperphosphorylation also disrupts interactions with RAB3GAP and RAB-GDI1. Our results reveal a mechanism by which pathogenic hyperactive LRRK2 may contribute to the altered synaptic homeostasis associated with characteristic non-motor and cognitive manifestations of PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2Parkinson DiseaseSynaptic Vesiclesrab3A GTP-Binding ProteinHumansAxonal TransportAxonsHomeostasisKinesinsPhosphorylation

Substanzen

KIF1A protein, humanKinesinsLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanrab3A GTP-Binding Protein

Autor:innen und Institutionen

  • Department of Physiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Aligning Science Across Parkinson's (ASAP) Collaborative Research Network , Chevy Chase, MD, USA.
  • Neuroscience Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

ORCID-Profile: Dan Dou, Jayne Aiken, Erika L F Holzbaur

Förderung

  • NIA NIH HHS
  • NIGMS NIH HHS
  • NINDS NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Michael J. Fox Foundation
  • Aligning Science Across Parkinson’s

Zitieren

APA

Dou, D., Aiken, J., & Holzbaur, E. L. F. (2024). RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors. Journal of Cell Biology. https://doi.org/10.1083/jcb.202307092

Vancouver

Dou D, Aiken J, Holzbaur ELF. RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors. Journal of Cell Biology. 2024. doi:10.1083/jcb.202307092

BibTeX
@article{Dou2024,
  author = {Dou, Dan and Aiken, Jayne and Holzbaur, Erika L F},
  title = {RAB3 phosphorylation by pathogenic LRRK2 impairs trafficking of synaptic vesicle precursors},
  journal = {Journal of Cell Biology},
  year = {2024},
  doi = {10.1083/jcb.202307092}
}
Kostenlos starten →